Johnson & Johnson JNJ
Johnson & Johnson is a global healthcare company that operates through two primary segments: Innovative Medicine and MedTech. The company develops, manufactures, and markets a broad range of products in pharmaceuticals, medical devices, and consumer health (though the consumer health business was spun off as Kenvue in 2023). Its Innovative Medicine segment focuses on discovering and commercializing treatments in therapeutic areas such as immunology, oncology, neuroscience, infectious diseases, and cardiovascular/metabolic conditions. The MedTech segment provides medical devices, equipment, and technologies for surgery, orthopedics, cardiovascular care, and vision health. Johnson & Johnson serves healthcare professionals, patients, hospitals, and consumers worldwide, with a business model centered on research and development, strategic acquisitions, and a diversified portfolio aimed at addressing critical medical needs across various stages of life.
LSTM Forecast
Forecast model is not trained yet for this market.
Train and backfill the LSTM forecast to surface a directional view here.